Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Paolo De Tos"'
Autor:
Alessandro Gronchi, Antonio Lopez-Pousa, Jean-Yves Blay, Silvia Stacchiotti, Emanuela Palmerini, Sandro Pasquali, Domenico Franco Merlo, Cleofé Romagosa, Vittorio Quagliuolo, Paolo G. Casali, Paolo De Tos, Silvia Bagué, Paola Collini, Jean Michel Coindre, Marta Barisella, Giovanni Grignani, Javier Martin Broto, Robert Diaz Beveridge, Chiara Castelli, Luca Braglia
Publikováno v:
Journal of Clinical Oncology. 39:11572-11572
11572 Background: The characteristics of immune contexture and its prognostic and predictive value in STS is left to be understood. This planned analysis of the ISG-STS-1001 trial, which compared neoadjuvant anthracycline + ifosfamide (AI) vs a histo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4fe5fff3844c752d837327b45e17f76
https://doi.org/10.1200/jco.2021.39.15_suppl.11572
https://doi.org/10.1200/jco.2021.39.15_suppl.11572
Autor:
Roberta Sanfilippo, Carlo Morosi, Pablo Luna Fra, Andrés Redondo, Paolo De Tos, Jean-Yves Blay, Javier Martinez-Trufero, Claudia Sangalli, Cleofé Romagosa, Josefina Cruz Jurado, Javier Peinado, Claudia Maria Valverde Morales, Marie Pierre Sunyach, Jesus G. Romero, Nadia Hindi, Antonio Gutierrez, Javier Martin Broto, Dominique Ranchère-Vince, Alessandro Gronchi
Publikováno v:
Journal of Clinical Oncology. 38:11514-11514
11514 Background: Myxoid liposarcoma (ML) exhibits especial sensitivity to trabectedin (T). In prospective series, T showed responses in 44% of patients (pts) with ML. ML is also sensitive to radiation therapy (RT) and preclinical data suggested radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0583d0368181bf5716907dec488eaae8
https://doi.org/10.1200/jco.2020.38.15_suppl.11514
https://doi.org/10.1200/jco.2020.38.15_suppl.11514